Rebecca joined SV in July 2018 as an Associate in the Dementia Discovery Fund (DDF) team, to help form and fund companies developing transformational new medicines for dementia.
Rebecca carries out due diligence of new deals, and provides strategic, BD, and operational support to existing companies in the DDF portfolio supporting them in bringing drugs from discovery to market.
Prior to joining the DDF, Rebecca was a Postdoctoral Scientist at Biogen in Cambridge, MA, conducting research on (neuro)inflammation in degenerative diseases like ALS, frontotemporal dementia, and Alzheimer's disease.
Outside of the DDF, Rebecca enjoys cycling, gardening, and travelling.
BA, Behavioral Biology, Johns Hopkins University; PhD, Brain and Cognitive Sciences, Massachusetts Institute of Technology